Page last updated: 2024-11-04

rolipram and Paraparesis, Tropical Spastic

rolipram has been researched along with Paraparesis, Tropical Spastic in 1 studies

Paraparesis, Tropical Spastic: A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. (Adams et al., Principles of Neurology, 6th ed, p1239)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatae, T1
Hara, H1
Kobayashi, T1
Watanabe, T1

Other Studies

1 other study available for rolipram and Paraparesis, Tropical Spastic

ArticleYear
The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM).
    Journal of the neurological sciences, 1997, May-01, Volume: 148, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Gene Expression; HTLV-I Infections; Humans

1997
chemdatabank.com